Peer-reviewedCC BYOpen heart20 Oct 2026

Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: an updated systematic review and meta-analysis.

Fahad Muhammad¹
Eyad Jamileh^2,3
Omar Farooq²
Mohammad Abusheikha⁴
Kaveh Hosseini⁵
Amr Abdin⁶
G André Ng^7,8,9,10
Ibrahim Antoun^11,10

11 affiliations

¹Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
²Department of Medicine, Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust, Blackburn, UK.
³School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
⁴Department of Medicine, Blackpool Victoria Hospital, Blackpool, Lancashire, UK.
⁵Department of Cardiology, Copenhagen University Hospital Department of Cardiology, Copenhagen, Denmark.
⁶Saarland University Hospital Internal Medicine III - Cardiology Angiology and Intensive Care Medicine, Homburg, Germany.
⁷Division of Cardiovascular Sciences Clinical Science Wing, University of Leicester, Leicester, UK [email protected].
⁸National Institute for Health Research, Leicester Biomedical Research Centre, Leicester, UK.
⁹Leicester British Heart Foundation Centre of Research Excellence, Leicester, UK.
¹⁰Department of Cardiology, University Hospitals of Leicester NHS Trust, Leicester, UK.
¹¹Division of Cardiovascular Sciences Clinical Science Wing, University of Leicester, Leicester, UK.

Read full text PDF DOI Cite

Clinical relevance of lead-induced tricuspid regurgitation after transvenous implantable cardioverter-defibrillator implantation in arrhythmogenic cardiomyopathy
Federico Migliore, Raimondo Pittorru, Alberto Cipriani +11
Europace3 Oct 2026Peer-reviewedCC BY 4.0Full textCardiovascular medicinePMC
Electrode perforation of a silicone breast implant in a subcutaneous implantable cardioverter-defibrillator carrier: A previously unreported device complication.
Theodoros Maximidou, Jonas Wörmann, Wolfram Malter +2
HeartRhythm case reports30 Jul 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
Intraoperative Application of the PRAETORIAN Score to Predict Optimal Subcutaneous Implantable Cardioverter‐Defibrillator Placement
Ken Yamazaki, Shingo Sasaki, Hiroaki Yokoyama +5
Journal of arrhythmia1 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
Inappropriate Therapy of Subcutaneous Implantable Cardioverter-Defibrillator Induced by an Electrical Bath
Motohiro Shingu, Tatsuya Nishikawa, Ryouta Yoshioka +11
Internal Medicine15 Oct 2026Peer-reviewedCC BY-NC-NDFull textCardiovascular medicineJ-STAGE
Neurologic presentation unmasks arrhythmogenic channelopathy: KCNH2 variant Long-QT syndrome managed with subcutaneous implantable cardioverter-defibrillator. A case report
Alexis Vallejos-Barrientos, Alessandra Centeno-Araujo, Richard Soto-Becerra +8
Archivos Peruanos de Cardiología y Cirugía Cardiovascular26 Sep 2026Peer-reviewedCC BY-NC 4.0Full textCardiovascular medicinePMC

Cite

BibTeX RIS

BibTeX

@article{muhammad2026subcutaneous,
  title = {{Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: an updated systematic review and meta-analysis.}},
  author = {Fahad Muhammad and Eyad Jamileh and Omar Farooq and Mohammad Abusheikha and Kaveh Hosseini and Amr Abdin and G André Ng and Ibrahim Antoun},
  journal = {Open heart},
  year = {2026},
  month = oct,
  doi = {10.1136/openhrt-2026-004443},
  url = {https://europepmc.org/article/MED/42901734},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Subcutaneous versus transvenous implantable cardioverter-defibrillator therapy: an updated systematic review and meta-analysis.
AU  - Fahad Muhammad
AU  - Eyad Jamileh
AU  - Omar Farooq
AU  - Mohammad Abusheikha
AU  - Kaveh Hosseini
AU  - Amr Abdin
AU  - G André Ng
AU  - Ibrahim Antoun
PY  - 2026
DA  - 2026/10/20
JO  - Open heart
DO  - 10.1136/openhrt-2026-004443
UR  - https://europepmc.org/article/MED/42901734
SN  - 2053-3624
ER  -

Related

Cite